
BCAL
BDX.AXBCAL Diagnostics Limited Price (BDX.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
246,225,497
(16.7484)%
Cash Flow Statement
BCAL Diagnostics LimitedCurrency: AUD
YEAR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||||||
Net Income | -467,632.00
+0% |
-429,957.00
-8% |
-696,360.00
+62% |
-1,524,970.00
+119% |
-3,385,493.00
+122% |
-5,061,755.00
+50% |
-6,400,191.00
+26% |
||||||||||||
Depreciation And Amortiz... | 14.04k | 3.55k | 7.73k | 0.00 | 20.61k | 113.62k | 579.79k | ||||||||||||
Deferred Income Tax | 0.00 | 0.00 | -273,025.00 | 0.00 | -369,584.00 | -225,680.00 | 0.00 | ||||||||||||
Stock-Based Compensat... | 0.00 | 0.00 | 142.04k | 176.26k | 369.58k | 225.68k | 573.29k | ||||||||||||
Change In Working Capital | |||||||||||||||||||
Accounts Receivables | -5,416.00 | -8,953.00 | -144,018.00 | -317,674.00 | -288,837.00 | -2,142,547.00 | 161.53k | ||||||||||||
Accounts Payables | -105,266.00 | -89,720.00 | 28.49k | 444.97k | 50.26k | 777.14k | 0.00 | ||||||||||||
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Other Working Capital | 0.00 | 0.00 | 0.00 | -1.00 | 0.00 | 0.00 | 449.93k | ||||||||||||
Other Non-Cash Items | 232.22k | 105.84k | 273.49k | 63.96k | 384.14k | 265.46k | 112.57k | ||||||||||||
Net Cash Provided By Op... | -470,814.00
+0% |
-525,011.00
+12% |
-661,651.00
+26% |
-1,206,420.00
+82% |
-3,219,320.00
+167% |
-6,048,091.00
+88% |
-4,523,085.00
-25% |
||||||||||||
Investing Activities | |||||||||||||||||||
Investments In Propert... | -14,030.00 | -7,472.00 | -3,807.00 | -3,850.00 | -4,025,762.00 | -362,471.00 | -1,150,948.00 | ||||||||||||
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | -4,000,000.00 | 0.00 | 0.00 | ||||||||||||
Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00M | 0.00 | ||||||||||||
Other Investing Activities | -86.00 | 0.00 | 0.00 | 0.00 | 4.00M | 4.00M | 0.00 | ||||||||||||
Net Cash Used For Inv... | -14,116.00
+0% |
-7,472.00
-47% |
-3,807.00
-49% |
-3,850.00
+1% |
-4,025,762.00
+104,465% |
3.64M
-190% |
-1,150,948.00
-132% |
||||||||||||
Financing Activities | |||||||||||||||||||
Debt Repayment | 500.00k | 0.00 | 300.00k | 0.00 | 0.00 | 0.00 | -256,884.00 | ||||||||||||
Common Stock Issued | 0.00 | 500.00k | 505.04k | 4.20M | 10.03M | 50.00k | 9.85M | ||||||||||||
Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | -621,794.00 | 0.00 | -444,830.00 | ||||||||||||
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
Other Financing Activities | 0.00 | 500.00k | 505.04k | 4.20M | 0.00 | -36,762.00 | -178,853.00 | ||||||||||||
Net Cash Used/Provide... | 500.00k
+0% |
500.00k
+0% |
805.04k
+61% |
4.20M
+422% |
9.41M
+124% |
13.24k
-100% |
8.97M
+67,682% |
||||||||||||
Effect Of Forex Changes... | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | ||||||||||||
Net Change In Cash | 15.07k | -32,483.00 | 139.58k | 2.99M | 2.16M | -2,397,324.00 | 3.30M | ||||||||||||
Cash At Beginning Of Per... | 294.06k | 309.13k | 276.64k | 416.23k | 3.41M | 5.57M | 3.17M | ||||||||||||
Cash At End Of Period | 309.13k | 276.64k | 416.23k | 3.41M | 5.57M | 3.17M | 6.47M | ||||||||||||
Additional Metrics: | |||||||||||||||||||
Operating Cash Flow | -470,814.00 | -525,011.00 | -661,651.00 | -1,206,420.00 | -3,219,320.00 | -6,048,091.00 | -4,523,085.00 | ||||||||||||
Capital Expenditure | -14,030.00 | -7,472.00 | -3,807.00 | -3,850.00 | -4,025,762.00 | -362,471.00 | -1,150,948.00 | ||||||||||||
Free Cash Flow | -484,844.00
+0% |
-532,483.00
+10% |
-665,458.00
+25% |
-1,210,270.00
+82% |
-7,245,082.00
+499% |
-6,410,562.00
-12% |
-5,674,033.00
-11% |